PABLO FRANCISCO BELAUNZARAN ZAMUDIO



DATOS GENERALES NOMBRAMIENTOS
Nombre completo   PABLO FRANCISCO BELAUNZARAN ZAMUDIO
Máximo nivel de estudios   ESPECIALIDAD
Antigüedad académica en la UNAM   1 año, 8 meses, 0 días

Último  TECNICO ACADEMICO ASOCIADO A MT No Definitivo
Facultad de Medicina
ESTIMULOS, PROGRAMAS, PREMIOS Y RECONOCIMIENTOS
* SNI II2019 - 2022
* SNI I2016 - 2018

INFORMACIÓN DE PUBLICACIONES
Firmas  
Belaunzaran P. Belaunzarán-Zamudio P.F. Belaunzaran-Zamudio, Pablo Belaunzaran-Zamudio, Pablo F. Francisco Belaunzaran-Zamudio, Pablo
ID's SCOPUS  
35085712600
ORCID's  
0000-0003-4775-4734
Áreas de conocimiento  
Biochemistry and molecular biology Clinical neurology Gerontology Immunology Infectious diseases
Medicine, general and internal Multidisciplinary sciences Pharmacology and pharmacy Psychology, clinical Public, environmental and occupational health
Tropical medicine Veterinary sciences Virology Agricultural and biological sciences (miscellaneous) Clinical psychology
Dermatology Epidemiology Genetics Health policy Immunology and allergy
Infectious diseases Medicine (miscellaneous) Multidisciplinary Neurology (clinical) Oncology
Pharmacology Pharmacology, toxicology and pharmaceutics (miscellaneous) Physics and astronomy (miscellaneous) Psychiatry and mental health Public health, environmental and occupational health
Veterinary (miscellaneous)
Coautorías con entidades de la UNAM  
  • Facultad de Medicina
Revistas en las que ha publicado  (30):
  1. AIDS RESEARCH AND HUMAN RETROVIRUSES, Estados Unidos America (2016, 2017, 2018, 2023)
  2. AM J EPIDEMIOL, Estados Unidos America (2020)
  3. ANNALS OF INTERNAL MEDICINE, Estados Unidos America (2022)
  4. ANTIVIRAL RESEARCH, Países Bajos (2019)
  5. BMC INFECTIOUS DISEASES, Reino Unido (2020, 2021, 2022)
  6. BULLETIN OF THE WORLD HEALTH ORGANIZATION, Suiza (2015)
  7. EBioMedicine, Países Bajos (2016)
  8. EPIDEMIOLOGY AND INFECTION, Estados Unidos America (2018)
  9. FRONTIERS IN IMMUNOLOGY, Suiza (2017, 2022)
  10. FRONTIERS IN NEUROLOGY, Suiza (2021)
  11. HIV MED, Reino Unido (2019, 2021)
  12. INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY, Estados Unidos America (2018)
  13. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, Reino Unido (2020)
  14. INTERNATIONAL JOURNAL OF STD & AIDS, Reino Unido (2018)
  15. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, Reino Unido (2019, 2020, 2021)
  16. Journal Of Virus Eradication, (2017)
  17. LANCET HIV, Reino Unido (2014, 2019, 2021)
  18. LANCET REGIONAL HEALTH-AMERICAS, Países Bajos (2022)
  19. MEDICAL MYCOLOGY, Reino Unido (2019)
  20. MOLECULAR MEDICINE, Estados Unidos America (2022)
  21. NATURE COMMUNICATIONS, Reino Unido (2019)
  22. Open Forum Infectious Diseases, Estados Unidos America (2015, 2018, 2020)
  23. Pathogens And Immunity, (2017)
  24. PLOS NEGLECTED TROPICAL DISEASES, Estados Unidos America (2021)
  25. PLOS ONE, Estados Unidos America (2017, 2018, 2020, 2022)
  26. PSYCHOTHERAPY RESEARCH, Estados Unidos America (2024)
  27. Public Health, Reino Unido (2022)
  28. QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, Reino Unido (2019)
  29. REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, México (2015, 2022)
  30. Skin Appendage Disorders, Suiza (2022)


Documentos indexados (WoS y Scopus)

# Título del documento Autores Año Rista Fuente Citas WoS Citas Scopus
1Development and content validity of EVAD: A novel tool for evaluating and classifying the severity of adverse events for psychotherapeutic clinical trialsCoautor: Belaunzarán-Zamudio P.F., Mejía-Castrejón J., Sierra-Madero J.G., Fresan-Orellana A., et al.2024PSYCHOTHERAPY RESEARCHWoS-id: 001044560100001
Scopus-id: 2-s2.0-85166950952
00
2Incomplete Antiretroviral Therapy Adherence Is Associated with Lower CD4-CD8 Ratio in Virally Suppressed Patients with HIV Infection in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Naranjo, Lizbeth, Caro-Vega, Yanink, Castillo-Mancilla, Jose R., et al.2023AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000936658100001
Scopus-id: 2-s2.0-85150000405
12
3Result Turnaround Time of RT-PCR for SARS-CoV-2 is the Main Cause of COVID-19 Diagnostic Delay: A Country-Wide Observational Study of Mexico and Colombia2ᵒ autor: Belaunzarán-Zamudio P.F., Núñez I., Caro-Vega Y.2022REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONWoS-id: 000751326000001
Scopus-id: 2-s2.0-85128160140
68
4Incidence of Cytomegalovirus disease and viral replication kinetics in seropositive liver transplant recipients managed under preemptive therapy in a tertiary-care center in Mexico City: a retrospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Fernández-García O.A., García-Juárez I., Vilatoba M., et al.2022BMC INFECTIOUS DISEASESWoS-id: 000755126200002
Scopus-id: 2-s2.0-85124797948
33
5Diagnostic precision of local and World Health Organization definitions of symptomatic COVID-19 cases: an analysis of Mexico's capitalCoautor y autor de correspondencia: Belaunzarán-Zamudio P.F., Núñez I., Caro-Vega Y.2022Public HealthWoS-id: 000784028900029
Scopus-id: 2-s2.0-85126528318
54
6Seroepidemiology of SARS-CoV-2 in healthcare personnel working at the largest tertiary COVID-19 referral hospitals in Mexico CityCoautor: Belaunzarán-Zamudio P.F., Dávila-Conn V., Soto-Nava M., Caro-Vega Y.N., et al.2022PLOS ONEWoS-id: 000784193600035
Scopus-id: 2-s2.0-85126685344
35
7Relationship Between Anemia and Systemic Inflammation in People Living With HIV and Tuberculosis: A Sub-Analysis of the CADIRIS Clinical TrialCoautor: Belaunzaran-Zamudio P.F., Araújo-Pereira M., Barreto-Duarte B., Arriaga M.B., et al.2022FRONTIERS IN IMMUNOLOGYWoS-id: 000821850100001
Scopus-id: 2-s2.0-85133844334
44
8Pyridostigmine reduces mortality of patients with severe SARS-CoV-2 infection: A phase 2/3 randomized controlled trialCoautor: Belaunzaran-Zamudio, Pablo F., Fragoso-Saavedra, Sergio, Núñez I., Audelo-Cruz, Belem M., et al.2022MOLECULAR MEDICINEWoS-id: 000880335300002
Scopus-id: 2-s2.0-85141555280
57
9Clinical effects of durability of immunosuppression in virologically suppressed ART-initiating persons with HIV in Latin America. A retrospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Rebeiro P.F., Shepherd B.E., et al.2022LANCET REGIONAL HEALTH-AMERICASWoS-id: 000904623700012
Scopus-id: 2-s2.0-85126975031
11
10Disparities in Dolutegravir Uptake Affecting Females of Reproductive Age With HIV in Low- and Middle-Income Countries After Initial Concerns About Teratogenicity An Observational StudyCoautor: Belaunzaran P., Romo M.L., Patel R.C., Edwards J.K., et al.2022ANNALS OF INTERNAL MEDICINEScopus-id: 2-s2.0-85123814148
014
11Nail changes in people living with human immunodeficiency virus: Observational and cross-sectional study in a third-level hospitalCoautor: Belaunzarán-Zamudio P.F., Flores-Bozo L.R., Méndez-Flores S., Olvera-Rodríguez V., et al.2022Skin Appendage DisordersScopus-id: 2-s2.0-85129768668
01
12The effect of protease inhibitor-based dual antiretroviral regimens on CD4/CD8 ratio during the first year of therapy in ART-naïve patients with HIV-infectionCoautor: Belaunzaran-Zamudio P.F., Figueroa M.I., Camiro-Zuñiga A., Sierra Madero J., et al.2021HIV MEDWoS-id: 000599516900001
Scopus-id: 2-s2.0-85097664776
22
13Antiretroviral therapy and Kaposi's sarcoma trends and outcomes among adults with HIV in Latin AmericaCoautor: Belaunzaran-Zamudio P.F., Castilho J.L., Kim A., Jenkins C.A., et al.2021JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000617060500003
Scopus-id: 2-s2.0-85100280898
44
14Comparison of clinical characteristics of zika and dengue symptomatic infections and other acute illnesses of unidentified origin in Mexico1ᵉʳ autor: Belaunzarán-Zamudio P.F., Mateja A., Guerra-De-blas P.C., Rincón-León H.A., et al.2021PLOS NEGLECTED TROPICAL DISEASESWoS-id: 000620636800004
Scopus-id: 2-s2.0-85102395176
65
15Comparison of the Impact of Zika and Dengue Virus Infection, and Other Acute Illnesses of Unidentified Origin on Cognitive Functions in a Prospective Cohort in Chiapas Mexico1ᵉʳ autor: Belaunzarán-Zamudio P.F., Ortega-Villa A.M., Mimenza-Alvarado A.J., Guerra-De-Blas P.D.C., et al.2021FRONTIERS IN NEUROLOGYWoS-id: 000636663400001
Scopus-id: 2-s2.0-85103613834
34
16Estimated life expectancy gains with antiretroviral therapy among adults with HIV in Latin America and the Caribbean: a multisite retrospective cohort studyCoautor: Belaunzaran-Zamudio P.F., Smiley C.L., Rebeiro P.F., Cesar C., et al.2021LANCET HIVWoS-id: 000645001400009
Scopus-id: 2-s2.0-85105894823
2730
17Different epidemiological profiles in patients with Zika and dengue infection in Tapachula, Chiapas in Mexico (2016?2018): an observational, prospective cohort studyCoautor: Belaunzarán-Zamudio P.F., Rincón León H.A., Caballero Sosa S., Ruiz E., et al.2021BMC INFECTIOUS DISEASESWoS-id: 000690903900003
Scopus-id: 2-s2.0-85114019614
11
18The HIV epidemic in Latin America: a time to reflect on the history of success and the challenges ahead2ᵒ autor: Belaunzarán-Zamudio P.F., Crabtree-Ramírez B., Cortes C.P., Morales M., et al.2020JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000522447100013
Scopus-id: 2-s2.0-85080839419
1420
19Myocardial inflammatory changes before and after antiretroviral therapy initiation in people with advanced human immunodeficiency virus diseaseCoautor: Belaunzaran-Zamudio P.F., Piñeirua-Menéndez A., Flores-Miranda R., Sánchez-Nava D., et al.2020Open Forum Infectious DiseasesWoS-id: 000577171000034
Scopus-id: 2-s2.0-85092090822
23
20A parallel-group, multicenter randomized, double-blinded, placebo-controlled, phase 2/3, clinical trial to test the efficacy of pyridostigmine bromide at low doses to reduce mortality or invasive mechanical ventilation in adults with severe SARS-CoV-2 infection: the Pyridostigmine In Severe COvid-19 (PISCO) trial protocolCoautor: Belaunzaran-Zamudio, Pablo F., Fragoso-Saavedra, Sergio, Iruegas-Nunez, David A., Quintero-Villegas, Alejandro, et al.2020BMC INFECTIOUS DISEASESWoS-id: 000582746200005
Scopus-id: 2-s2.0-85092768750
910
21The population impact of late presentation with advanced HIV disease and delayed antiretroviral therapy in adults receiving HIV care in Latin America1ᵉʳ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y.N., Shepherd B.E., Rebeiro P.F., et al.2020AM J EPIDEMIOLScopus-id: 2-s2.0-85082794485
023
22Frequency of non-communicable diseases in people 50 years of age and older receiving HIV care in Latin America1ᵉʳ autor: Belaunzaran-Zamudio P.F., Caro-Vega Y., Giganti M.J., Castilho J.L., et al.2020PLOS ONEScopus-id: 2-s2.0-85086691765
014
23Patterns of signs, symptoms, and laboratory values associated with Zika, dengue, and undefined acute illnesses in a dengue endemic region: Secondary analysis of a prospective cohort study in southern MexicoCoautor: Belaunzarán-Zamudio P.F., Hunsberger S., Ortega-Villa A.M., Powers J.H., et al.2020INTERNATIONAL JOURNAL OF INFECTIOUS DISEASESScopus-id: 2-s2.0-85089221780
08
24An immunocompromised patient & multiorgan cystic echinococcosisCoautor: Belaunzaran-Zamudio P.F., Lopez Luis B.A., Valdivia-Cayoja A.R., Soto-Ramírez L.E.2019QJM-AN INTERNATIONAL JOURNAL OF MEDICINEWoS-id: 000462590800010
Scopus-id: 2-s2.0-85062504880
12
25Serial real-time RT-PCR and serology measurements substantially improve Zika and Dengue virus infection classification in a co-circulation areaCoautor: Belaunzarán-Zamudio P.F., Gouel-Cheron A., Lumbard K., Hunsberger S., et al.2019ANTIVIRAL RESEARCHWoS-id: 000499939700012
Scopus-id: 2-s2.0-85074984732
913
26Temporal changes in ART initiation in adults with high CD4 counts in Latin America: a cohort studyCoautor: Belaunzarán-Zamudio P.F., Crabtree-Ramírez B.E., Caro-Vega Y., Shepherd B.E., et al.2019JOURNAL OF THE INTERNATIONAL AIDS SOCIETYWoS-id: 000505786500012
Scopus-id: 2-s2.0-85077014848
23
27Mexico's fragmented health system as a barrier to HIV care2ᵒ autor: Belaunzaran-Zamudio P.F., Sierra-Madero J.G., Crabtree-Ramírez B., Magis-Rodriguez C.2019LANCET HIVScopus-id: 2-s2.0-85060961011
012
28Immediate treatment of acute HIV in a tertiary healthcare center: bridging gaps in communication using smartphonesCoautor: Belaunzarán-Zamudio P.F., Perez-Patrigeon S., Camiro-Zúñiga A., Jaramillo-Jante M.R., et al.2019HIV MEDScopus-id: 2-s2.0-85063645559
02
29Differential human antibody repertoires following Zika infection and the implications for serodiagnostics and disease outcomeCoautor: Belaunzarán-Zamudio P.F., Ravichandran S., Hahn M., Ramos-Castañeda J., et al.2019NATURE COMMUNICATIONSScopus-id: 2-s2.0-85064956193
043
30Progressive disseminated histoplasmosis in Latin America and the Caribbean in people receiving highly active antiretroviral therapy for HIV infection: A systematic reviewCoautor: Belaunzarán-Zamudio P.F., Cano-Torres J.O., Olmedo-Reneaum A., Esquivel-Sánchez J.M., et al.2019MEDICAL MYCOLOGYScopus-id: 2-s2.0-85068832857
011
31Evaluating the care cascade after antiretroviral therapy initiation in Latin AmericaCoautor: Belaunzaran-Zamudio, Pablo, Wolff, Marcelo J., Cortes, Claudia P., Mejia, Fernando A., et al.2018INTERNATIONAL JOURNAL OF STD & AIDSWoS-id: 000418610600001
Scopus-id: 2-s2.0-85042463178
99
32Is substance use associated with HIV cascade outcomes in Latin America?Coautor: Belaunzarán-Zamudio P.F., De Boni R.B., Peratikos M.B., Shepherd B.E., et al.2018PLOS ONEWoS-id: 000427473500058
Scopus-id: 2-s2.0-85044070394
1112
33Durability of efavirenz compared with boosted protease inhibitor-based regimens in antiretroviral-naïve patients in the Caribbean and central and South America2ᵒ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Crabtree-Ramírez B.E., Shepherd B.E., et al.2018Open Forum Infectious DiseasesWoS-id: 000429449800001
Scopus-id: 2-s2.0-85043402295
67
34Association between Frailty and HIV-Associated Neurodegenerative Disorders among Older Adults Living with HIV2ᵒ autor: Belaunzarán-Zamudio P.F., Zamudio-Rodríguez A., Sierra-Madero J.G., Cuellar-Rodríguez J., et al.2018AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000431182400008
Scopus-id: 2-s2.0-85046690418
2128
35Trends in proportion of older HIV-infected people in care in Latin America and the Caribbean: A growing challenge2ᵒ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y., Crabtree-Ramírez B., Shepherd B.E., et al.2018EPIDEMIOLOGY AND INFECTIONWoS-id: 000439936400016
Scopus-id: 2-s2.0-85047875295
109
36Correlates of depressive symptoms among older adults living with HIVCoautor: Belaunzarán-Zamudio P.F., Avila-Funes J.A., Zamudio-Rodríguez A., Muñoz-Nevárez L.A., et al.2018INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRYWoS-id: 000449080200011
Scopus-id: 2-s2.0-85051293721
33
37Correction: Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico (PLoS ONE (2018) 13: 11(e0207203) Doi : 10.1371/journal.pone.0207203)2ᵒ autor: Belaunzarán-Zamudio P.F., Marfil-Garza B.A., Gulias-Herrero A., Zuñiga A.C., et al.2018PLOS ONEWoS-id: 000454149400083
Scopus-id: 2-s2.0-85058917122
01
38Risk factors associated with prolonged hospital length-of-stay: 18-year retrospective study of hospitalizations in a tertiary healthcare center in Mexico2ᵒ autor: Belaunzarán-Zamudio P.F., Marfil-Garza B.A., Gulias-Herrero A., Zuñiga A.C., et al.2018PLOS ONEScopus-id: 2-s2.0-85056395067
047
39Burden of HIV, Syphilis, and Hepatitis B and C Among Inmates in a Prison State System in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Mosqueda-Gomez, Juan L., Macias-Hernandez, Alejando, Rodriguez-Ramirez, Sonia, et al.2017AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000402996700003
Scopus-id: 2-s2.0-85020387884
1622
40Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico1ᵉʳ autor: Belaunzaran-Zamudio, Pablo F., Mosqueda-Gomez, Juan L., Macias-Hernandez, Alejando, Sierra-Madero, Juan G., et al.2017PLOS ONEWoS-id: 000404541500039
Scopus-id: 2-s2.0-85021382214
1919
41Country of residence is associated with distinct inflammatory biomarker signatures in HIV-infected patientsCoautor: Belaunzaran-Zamudio, Pablo F., Manion, Maura, Andrade, Bruno B., DerSimonian, Rebecca, et al.2017Journal Of Virus EradicationWoS-id: 000409108800003
120
42Add-on Pyridostigmine enhances CD4+ T-cell recovery in HIV-1-infected immunological non-responders: A proof-of-concept studyCoautor: Belaunzarán-Zamudio P.F., Valdés-Ferrer S.I., Crispín J.C., Rodríguez-Osorio C.A., et al.2017FRONTIERS IN IMMUNOLOGYWoS-id: 000413096600001
Scopus-id: 2-s2.0-85031719421
1214
43Immunologic effects of maraviroc in hiv-infected patients with severe cd4 lymphopenia starting antiretroviral therapy: A sub-study of the cadiris trial1ᵉʳ autor: Belaunzarán-Zamudio P.F., Azzoni L., Canaday D.H., Caro-Vega Y.N., et al.2017Pathogens And ImmunityScopus-id: 2-s2.0-85066139725
03
44Correlates of Prevalent Disability Among HIV-Infected Elderly Patients2ᵒ autor: Francisco Belaunzaran-Zamudio, Pablo, Alberto Avila-Funes, Jose, Tamez-Rivera, Oscar, Crabtree-Ramirez, Brenda, et al.2016AIDS RESEARCH AND HUMAN RETROVIRUSESWoS-id: 000369760500008
Scopus-id: 2-s2.0-84958959593
1517
45Vitamin D, D-dimer, Interferon gamma, and sCD14 Levels are Independently Associated with Immune Reconstitution Inflammatory Syndrome: A Prospective, International StudyCoautor: Belaunzaran-Zamudio, Pablo F., Musselwhite, Laura W., Andrade, Bruno B., Ellenberg, Susan S., et al.2016EBioMedicineWoS-id: 000370806400022
Scopus-id: 2-s2.0-84954348274
3234
46Surveillance of Oseltamivir-Resistant Influenza A(H1N1)pdm09 in Guanajuato State, Mexico from 2009 to 20122ᵒ autor: Belaunzarán-Zamudio P.F., Mosqueda-Gómez J.L., Barba A., Córdova-Villalobos J.A., et al.2015REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATIONScopus-id: 2-s2.0-85040636133
01
47Monitoring of HIV treatment in seven countries in the WHO region of the Americas1ᵉʳ autor: Belaunzarán-Zamudio P.F., Caro-Vega Y.N., Shepherd B.E., Crabtree-Ramírez B.E., et al.2015BULLETIN OF THE WORLD HEALTH ORGANIZATIONScopus-id: 2-s2.0-84938538216
018
48CD4 response up to 5 years after combination antiretroviral therapy in human immunodeficiency virus-infected patients in Latin America and the Caribbean2ᵒ autor: Belaunzarán-Zamudio P.F., Luz P.M., Crabtree-Ramírez B., Caro-Vega Y., et al.2015Open Forum Infectious DiseasesScopus-id: 2-s2.0-84978328152
07
49Effect of the CCR5 antagonist maraviroc on the occurrence of immune reconstitution inflammatory syndrome in HIV (CADIRIS): A double-blind, randomised, placebo-controlled trialCoautor: Belaunzarán-Zamudio P.F., Sierra-Madero J.G., Ellenberg S.S., Rassool M.S., et al.2014LANCET HIVScopus-id: 2-s2.0-84921985871
050

Obras con ISBN (Indautor)

# Título del documento Autores Alcance Año ISBN Fuente
1Perspectivas Multidimensionales Del VihBelaunzarán Zamudio, Pablo Francisco, Torres Cruz, César, Caro Vega, Yanink Neried, Libro Completo20209786072818941INDAUTOR

Proyectos

# Nombre Participantes Convocatoria Fecha Inicio Fecha Fin
1067 2015 Condicones de vida que influyen en las personas que no continúan con la atención con una prueba rápida reactiava de VIH caso: Clínica Especializada CondesaPABLO FRANCISCO BELAUNZARAN ZAMUDIO,
Ingresos Propios02-06-201502-06-2018
2Estudio de prevalencia de tuberculosis latente en personas con VIH atendidas en los servicios de salud especializados en VIH y sida de la Ciudad de México.PABLO FRANCISCO BELAUNZARAN ZAMUDIO,
Ingresos Propios01-12-201501-12-2020

Participación en Comités de Tesis

# Título del documento Tipo de Tesis Sinodales Autores Año Entidad Url
1Evaluación de metas de control de diabetes en pacientes con VIHTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; ALFONSO GULIAS HERRERO; JULIO CESAR HERNANDEZ JIMENEZ; Álvarez Morales, Rigoberto Doroteo; 2018Escuela Nacional Colegio de Ciencias y Humanidades "Sur", Facultad de Medicina,
2Deterioro neurocognitivo asociado a VIH en pacientes atendidos en el INCMNSZ, respuesta clínica a largo plazo posterior al inicio de terapia antirretroviral altamente activaTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; Ramírez González, Luis Esteban; 2015
3Marcadores pronósticos de recuperación inmune en una cohorte de pacientes con VIH avanzadoTesis de EspecialidadPABLO FRANCISCO BELAUNZARAN ZAMUDIO; YANINK NERIED CARO VEGA; López Martínez, Alondra; 2013

Docencia Impartida

# Entidad Nivel Asignatura Año Semestre Alumnos
1Facultad de MedicinaDoctoradoESTANCIA SOCIOMÉDICA20212022-11
2Facultad de MedicinaDoctoradoTUTORÍA VII20212022-11

Descargar PDF